Skip to main content

Table 1 Clinical profiles of AIA patients and ATA cases.

From: Positive Association between Aspirin-Intolerant Asthma and Genetic Polymorphisms of FSIP1: a Case-Case Study

Clinical profile

Asthmatics (all subject)

AIA

ATA

N

592

163

429

Age of first medical examination (mean (range))

46.15 (15.40-77.88)

43.13 (17.22-72.73)

47.30 (15.40-77.88)

Height (cm)

160.78 ± 8.63

161.72 ± 8.69

160.42 ± 8.39

Weight (kg)

62.81 ± 10.84

61.25 ± 10.38

63.40 ± 10.97

Fall rate (%)

9.27 ± 13.24

24.63 ± 16.11

3.54 ± 4.85

Blood eosinophil (%)

6.01 ± 5.73

5.96 ± 5.21

6.03 ± 5.92

FVC %, predicted

88.54 ± 14.08

90.35 ± 14.04

87.85 ± 14.05

FEV1 %, predicted

90.54 ± 16.97

87.58 ± 16.94

91.66 ± 16.87

PC20, methacholine (mg/ml)

6.43 ± 8.67

5.02 ± 7.83

6.91 ± 8.90

Total IgE (IU/ml)*

156 (62, 394)

164 (78, 357)

154 (53, 416)

Sex (male/female)

206/386

59/104

147/282

Current Smoker (%)

27.70

21.47

30.07

Positive rate of skin test (%)

56.42

52.76

57.81

  1. Fall rate refers to the decline of FEV1% by aspirin provocation.
  2. *Total IgE value is shown as median (25% interquartile interval, 75% interquartile interval).
  3. AIA, aspirin-intolerant asthma; ATA, aspirin-tolerant asthma; FVC, forced vital capacity; FEV1, forced expiratory volume in 1 second.